Senate rejects ARENA fossil fuel plans
The Senate took advantage of the absence of Senator Pauline Hanson to reject government plans to extend the remit of the Australian Renewable Energy Agency to allow it to invest in so-called ‘low-emissions technologies’. The opposition, greens and cross-benchers feared this would divert funds set aside for investment in renewables to support coal and gas projects, and rejected changes proposed by energy minister Angus Taylor. Taylor said on Twitter: “Labor have shown their true colours – opposing investment in new clean technologies which will create jobs and economic opportunities.”
EMVision to work with Metro South on clinical trials.
Medtech manufacturer EMVision Medical Devices has signed an agreement with healthcare group Metro South Health to develop the company’s imaging technologies to advance patient care. The company, which is commercialising an imaging technology that utilises microwaves to image the human brain, said the groups would collaborate on R&D activities, including potential clinical studies. Metro South will provide access to neurology, radiology and critical care expertise. Metro South runs five hospitals including the Princess Alexandra Hospital in Brisbane.
Fortescue secures Tasmanian hydrogen site
Fortescue Metals Group has taken an option on land owned by TasPorts at Bell Bay for the construction of a green hydrogen plant. Fortescue Future Industries plans a 250MW green hydrogen and ammonia plant powered by hydro-electricity. Japan’s IHI Corporation is negotiating to take green ammonia exports.
Viraleze claims questioned by UK regulator
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has raised questions over promotional claims made concerning pharmaceutical developer Starpharma’s Viraleze antiviral nasal spray. The questions, which cover references to Covid-19, do not relate to safety or quality. However Starpharma has temporarily paused sales of the spray in the UK.
Picture: EMVision Medical Devices
Subscribe to our free @AuManufacturing newsletter here.